Research Papers

25 of 343 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Natural history, clinical characteristics, outcomes, and long-term follow-up of pain-free chronic pancreatitis.
Ahmed A; Shah I; Bocchino R; Freedman SD; Kothari DJ; Sheth SG.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma.
Rao WQ; Lin Z; Jiang J; Wang JW; Lin ZF; Fu R; Chen WL; Chen YM; Peng XE; Hu ZJ.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Ultrasound-guided fine-needle aspiration/biopsy-based pancreatic organoids establishment: an alternative model for basi…
Chen S; Wang M; Liu L; Wang G; Wang L; Zhong C; Gao C; Wu W; Li L.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistul…
Abou Yassine A; Al Moussawi H; Kreidieh M; Dahabra L; Al-Roubaie M; Satapathy S.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
An update on the management of non-variceal upper gastrointestinal bleeding.
Alali AA; Barkun AN.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
New indication area in intersphincteric resection: transanal total mesorectal excision combined with intersphincteric r…
Yüksel BC.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
2/6 Transparent
Key quality indicators in colonoscopy.
Rex DK.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Intensity-specific considerations for exercise for patients with inflammatory bowel disease.
Ordille AJ; Phadtare S.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Oxaliplatin plus irinotecan vs irinotecan as second-line treatment in pancreatic cancer patients: a randomized-controll…
Zhang H; Tong Z; Liu L; Fu Q; Zhu X; Dai X; Bao X; Fang W; Zheng Y; Zhao P.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Enterocolic phlebitis: a rare cause of bowel ischemia and review of the literature.
Bowee S; Matter SB; Dawson H; Inglin RA.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Artificial intelligence empowers the second-observer strategy for colonoscopy: a randomized clinical trial.
Wang P; Liu XG; Kang M; Peng X; Shu ML; Zhou GY; Liu PX; Xiong F; Deng MM; Xia HF; Li JJ; Long XQ; Song Y; Li LP.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Re-recognition of <i>BMPR1A</i>-related polyposis: beyond juvenile polyposis and hereditary mixed polyposis syndrome.
Zhao ZY; Lei Y; Wang ZM; Han H; Xing JJ; Xu XD; Gao XH; Zhang W; Yu ED.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A new radiomics approach combining the tumor and peri-tumor regions to predict lymph node metastasis and prognosis in g…
Yang Y; Chen H; Ji M; Wu J; Chen X; Liu F; Rao S.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Targeting <i>KRAS G12C</i> mutations in colorectal cancer.
Zhao MH; Wu AW.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistu…
Nazari H; Alborzi F; Heirani-Tabasi A; Hadizadeh A; Asbagh RA; Behboudi B; Fazeli MS; Rahimi M; Keramati MR; Keshvari A; Kazemeini A; Soleimani M; Ahmadi Tafti SM.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Advancing endoscope for cervicothoracic junction: a feasibility study of small incision-assisted submucosal tunnel endo…
Xu E; Guo W; Qi Z; He D; Lu P; Chen Z; Liu J; Zhong Y.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Post-operative prevention and monitoring of Crohn's disease recurrence.
Lee KE; Cantrell S; Shen B; Faye AS.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Endo-anesthesia: a primer.
Bazerbachi F; White RM; Forbes N; Goudra B; Abu Dayyeh BK; Chandrasekhara V; Sweitzer B.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The relationship between zinc deficiency and infectious complications in patients with hepatitis B virus-related acute-…
Li X; Wang L; He N; Zhang Y; Pang J; Wang H; Yu M; Mei Y; Peng L; Xu W.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thr…
Biolato M; Vitale F; Marrone G; Miele L; Grieco A.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Single-operator-conducted natural orifice specimen extraction surgery (NOSES) for sigmoid colon cancer.
Huang J; Lai S; Yao Q; Pei F; Zhao Y; Huang M.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Genetic variants in promoter region of <i>TFR2</i> is associated with the risk of non-alcoholic fatty liver disease in …
Pan X; Peng H; Zhang J; Wu Y; Hu Z; Peng XE.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Post-operative anastomotic leakage and collagen changes in patients with rectal cancer undergoing neoadjuvant chemother…
Jiang W; Wang H; Zheng J; Zhao Y; Xu S; Zhuo S; Wang H; Yan J.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pregnancy and Crohn's disease: concerns and assurance of medical therapy.
Chowdhury R; Kane SV.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
2/6 Transparent
Biologics: how far can they go in Crohn's disease?
Dunleavy KA; Pardi DS.
Gastroenterol Rep (Oxf) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared